No Data
No Data
Beam Therapeutics To Present At TD Cowen Health Care Conference; Webcast At 1:50 PM ET
Beam Therapeutics Is Maintained at Sector Perform by Scotiabank
Express News | Beam Therapeutics Inc : Scotiabank Raises Target Price to $25 From $24
H.C. Wainwright Maintains Beam Therapeutics(BEAM.US) With Buy Rating, Maintains Target Price $80
JonesTrading Maintains Beam Therapeutics(BEAM.US) With Hold Rating
Cautious Optimism for Beam Therapeutics Amid Upcoming Milestones and Financial Considerations
sooogod : nbis.
GOGOY : Tem will be the next